Discovery
Define the biological question, cohort context, and decision need.
applications /
Precision Oncology
Connect molecular signals to interpretable oncology research.
Research concepts connecting molecular signals, governed assays, and interpretable evidence for oncology programs.
- Biomarker research
- Precision measurement
- Evidence governance
Overview
Precision begins with evidence quality.
Medein combines biomarker research, direct molecular measurement, governed interpretation, and validation planning for precision-oncology programs.
Platform approach
Counting
Select measurement strategies appropriate to signal abundance and matrix.
Interpretation
Connect molecular evidence to uncertainty-aware models.
Validation
Design analytical and translational evidence gates.
Workflow
Research pathway
Each transition creates a review point for evidence, assumptions, ownership, and next-step decisions.
- 01Discover
- 02Count
- 03Interpret
- 04Validate
- 05Report
Program fit
Connected portfolio
Public examples describe where a conversation may begin. Final scope, evidence requirements, availability, and access are confirmed through review.
LungDefend
A governed product concept aligned to precision-oncology research workflows.
Bremony and ProsGlad
Product concepts presented with explicit evidence and regional status.
DeteDx
A detection-oriented concept connected to precision-assay evidence.
Public evidence framework
What this page can—and cannot—communicate.
Content statusPublic platform conceptReviewed for public communication
Evidence accessPublic overview; deeper evidence by qualified requestSubject to scientific and access review
Review focusScope, assumptions, limitations, and next evidence gateMaintained by the program owner
Important limitationNo diagnostic, treatment, survival, or clinical benefit claim is made for these research concepts.No universal or clinical performance is implied
Collaboration
Explore a program with Medein.
Share the scientific or product context your team wants to evaluate.